Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03801018
Other study ID # 2018-53
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 7, 2019
Est. completion date January 6, 2021

Study information

Verified date December 2018
Source Assistance Publique Hopitaux De Marseille
Contact Catherine Guillemain, PU-PH
Phone 4 91 38 29 00
Email catherine.guillemain@ap-hm.fr
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Assisted reproductive techniques (ART) is very framed in France by principles initially stated by the french CECOS Federation of (Centre d'Etude et de Conservation des Oeufs et du Sperme) and then included in the bioethic law. Since 1973, more than 50 000 births have been achieved through sperm donation, and the investigators have little knowledge of what information parents pass on to their children about how they have conceived. However, it is accepted that the secrecy about the use of donated gametes has negative consequences.

The investigators propose an original project never initiated in France, to evaluate at the national level the disclosure to the people conceived using donated gametes, thanks to an interdisciplinary research crossing medical approach (biology, psychology) and social sciences (anthropology, sociology). It uses a quantitave and qualitative approach relying on one hand on online questionnaires and on the other hand on semi-structured interviews, aimed at parent who have used ART with donated gametes and people conceived using donated gametes. This dual approach will outline broad trends in sharing information about the use of donated gametes, explore in depth the motivation of parental choices for information, and better understand the family and biographical dynamics associated with information sharing or its absence. Moreover, this project will lead to evaluate the way in which the parents received the messages of the professionnals involved in ART with donation gametes, in terms of disclosure to offspring.

The conclusions will highlight the most important elements that will be useful to the professionnals involved in gamete donation to help them improve their practices upstream, during, and after the completion of the ART with gamete donation.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date January 6, 2021
Est. primary completion date January 6, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

For the parents :

- Parents of children from sperm donation

- Parents of children from oocyte donation

- Major people

- Parents who have benefited from taking over in France or taking charge in a foreign country, in a legal framework different from ours

- People who gave their non-opposition

For the childs :

- Person born by sperm donation

- Person born by Egg donation

- Major person

- Person who gave their non-opposition

Exclusion Criteria:

- Minor person

- No one who has used the amp or anyone who is not from an amp with gamete donation.

- People who have not expressed their non-opposition

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Questionnary and Interviews
An internet platform dedicated to the anonymous survey will be set up by the communication department and the digital System Department of the promoter Public assistance hospitals in Marseille, the data Processing manager. It would deplore anonymous questionnaires accessible from a dedicated web page. People will therefore respond to a national survey on the basis of volunteering and anonymity. Interviews, lasting one to two hours, will be fully transcribed and processed anonymously. The interviews will seek to collect data on the modalities, conditions and effects of the circulation (or retention) of information on the use of donation, throughout the lives of individuals and families, in a cross-analysis of Viewpoints of parents and people born of donation.

Locations

Country Name City State
France service de Biologie de la Reproduction-CECOS Marseille Marseille Cedex 5

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluate, for parents who have informed their child, how and when the information was circulated. An internet platform dedicated to the anonymous survey will be set up by the communication department and the digital System Department of the promoter Public assistance hospitals in Marseille.
A first questionnaire will be for the parents, the second questionnaire will be for people born through a donation. They will include closed questions, drop-down menus and rare open questions. The succession of questions will be studied in order to check the consistency of the answers. Replies to the questionnaires can be extracted anonymously.
The interviews will seek to collect data on the modalities, conditions and effects of the circulation (or retention) of information on the use of donation, throughout the lives of individuals and families, in a cross-analysis of Viewpoints of parents and people born of Don.
A cross-analysis of quantitative and qualitative data will be carried out.
2 Years
See also
  Status Clinical Trial Phase
Completed NCT01297465 - PERgoveriS In Stratified Treatment for Assisted Reproductive Technique Phase 3
Completed NCT02787811 - Predictors of Success of IUI in Unexplained Infertility N/A
Recruiting NCT04531644 - Double Stimulation in Women With Low Prognosis in ART N/A
Active, not recruiting NCT02222831 - Optimizing IVF Treatment - the Impact of Time-lapse Culture and Preimplantation Factor (PIF) on Embryo Development. N/A
Completed NCT03660007 - Incidence of Pulmonary and Venous Thromboembolism in IVF Pregnancies After Fresh and Frozen Embryo Transfer
Completed NCT06199960 - Dual Ovarian Stimulation (Duostim) and Shanghai Protocols in Poor Ovarian Responders Phase 3